Arthritis Australia welcomes proposals to reduce the cost of medicines
Discover more...
-
Shortage of Abatacept (Orencia®) – update
Bristol Myers Squibb (BMS), the manufacturer of abatacept (Orencia®), has announced ashortage of both the ClickJect (autoinjector) and pre-filled syringe subcutaneous formulations of the medication....
-
Arthritis Australia welcomes cheaper arthritis medicines
More medicines now eligible for 60 day dispensing from March 1 2024 [Sydney, Australia] Arthritis Australia has welcomed access to cheaper medicines commonly used to...
-
Anticipated Shortage of Abatacept (Orencia®)
Bristol Myers Squibb (BMS), the manufacturer of abatacept (Orencia®), has recently announced an expected shortage of both the ClickJect (autoinjector) and pre-filled syringe subcutaneous formulations...
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox: